Henrik Luessen

Henrik Luessen is the Founder and Managing Director at Tytonis BV, where they lead a multidisciplinary team of former pharmaceutical executives. They previously held significant roles as Manager of Corporate Development at LTS Lohmann Therapy Systems and Director of Business & Corporate Development at OctoPlus, contributing to the company's growth from 16 to 140 employees. As an interim Chief Business Officer at Activaero, Henrik worked on advancing the company in inhalation therapy, and they also served as Chief Business Officer for various organizations, including Promethera Biosciences and Sapreme Technologies. Henrik earned a Master's Degree in Pharmaceutical Sciences from Universität Hamburg and a Ph.D. in Pharmaceutics from Leiden University.